Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Exclusion Criteria

• •1. Patient with significantly compromised visual acuity in the study eye due to concomitant ocular conditions.
• •2. Patients who have undergone intraocular surgery within the last 2 months.
• •3. Patient participating in any other investigational drug study.
• •4. Use of an investigational drug or treatment related or unrelated to their condition within 30 days prior to receipt of study medication.
• •5. Inability to obtain photographs to document choroidal neovascularization (CNV) (including difficulty with venous access).
• •6. Patient with significant liver disease or uremia.
• •7. Patient with known adverse reaction to fluorescein and indocyanine green or iodine.
• •8. Patient has a history of any medical condition which would preclude scheduled visits or completion of study
• •9. Patient has had insertion of scleral buckle in the study eye
• •10. Patient has received radiation treatment
• •11. Patient is on anticoagulant therapy with the exception of aspirin
• •12. Patient is pregnant or nursing.